Cargando…

Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study

Long-term use of gastric-acid-suppressive drugs is known to be associated with several adverse effects. However, the association between enteric infection and acid suppression therapy is still uncertain. This study aimed to evaluate the association between gastric acid suppression and the risk of en...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Chia-Jung, Lin, Cheng-Yu, Chen, Chun-Wei, Hsu, Chiu-Yi, Hsieh, Sen-Yung, Chiu, Cheng-Tang, Lin, Wey-Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621954/
https://www.ncbi.nlm.nih.gov/pubmed/34834415
http://dx.doi.org/10.3390/jpm11111063
_version_ 1784605579759583232
author Kuo, Chia-Jung
Lin, Cheng-Yu
Chen, Chun-Wei
Hsu, Chiu-Yi
Hsieh, Sen-Yung
Chiu, Cheng-Tang
Lin, Wey-Ran
author_facet Kuo, Chia-Jung
Lin, Cheng-Yu
Chen, Chun-Wei
Hsu, Chiu-Yi
Hsieh, Sen-Yung
Chiu, Cheng-Tang
Lin, Wey-Ran
author_sort Kuo, Chia-Jung
collection PubMed
description Long-term use of gastric-acid-suppressive drugs is known to be associated with several adverse effects. However, the association between enteric infection and acid suppression therapy is still uncertain. This study aimed to evaluate the association between gastric acid suppression and the risk of enteric infection. Materials and Methods: We conducted a population-based case-control study using the data from Chang Gung Research Database (CGRD) in Taiwan. Between January 2008 and December 2017, a total of 154,590 adult inpatients (age > 18) were identified. A pool of potential eligible controls according to four propensity scores matching by sex, age, and index year were extracted (n = 89,925). Subjects with missing data or who received less than 7 days of proton pump inhibitors (PPIs) and/or H2-receptor antagonists (H2RAs) were excluded. Finally, 17,186 cases and 69,708 corresponding controls were selected for analysis. The use of PPIs and H2RAs, the result of microbiological samples, and co-morbidity conditions have been analyzed. Confounders were controlled by conditional logistic regression. Results: 32.84% of patients in the case group used PPIs, compared with 7.48% in the control group. Of patients in the case group, 9.9% used H2RAs, compared with 6.9% in the control group. Of patients in the case group, 8.3% used a combination of PPIs and H2RAs, compared with 2.7% in the control group. The most common etiological pathogens were Enterococcus (44.8%), Clostridioides difficile (34.5%), and Salmonella spp. (10.2%). The adjusted odds ratio (OR) for PPI use with enteric infection was 5.526 (95% confidence interval [CI], 5.274–5.791). For H2RAs, the adjusted odds ratio was 1.339 (95% confidence interval [CI], 1.261–1.424). Compared to the control group, persons with enteric infection had more frequent acid-suppressive agent usage. Conclusions: This study demonstrates that gastric-acid-suppressive drug use is associated with an increased risk of enteric infection after adjusting for potential biases and confounders.
format Online
Article
Text
id pubmed-8621954
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86219542021-11-27 Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study Kuo, Chia-Jung Lin, Cheng-Yu Chen, Chun-Wei Hsu, Chiu-Yi Hsieh, Sen-Yung Chiu, Cheng-Tang Lin, Wey-Ran J Pers Med Article Long-term use of gastric-acid-suppressive drugs is known to be associated with several adverse effects. However, the association between enteric infection and acid suppression therapy is still uncertain. This study aimed to evaluate the association between gastric acid suppression and the risk of enteric infection. Materials and Methods: We conducted a population-based case-control study using the data from Chang Gung Research Database (CGRD) in Taiwan. Between January 2008 and December 2017, a total of 154,590 adult inpatients (age > 18) were identified. A pool of potential eligible controls according to four propensity scores matching by sex, age, and index year were extracted (n = 89,925). Subjects with missing data or who received less than 7 days of proton pump inhibitors (PPIs) and/or H2-receptor antagonists (H2RAs) were excluded. Finally, 17,186 cases and 69,708 corresponding controls were selected for analysis. The use of PPIs and H2RAs, the result of microbiological samples, and co-morbidity conditions have been analyzed. Confounders were controlled by conditional logistic regression. Results: 32.84% of patients in the case group used PPIs, compared with 7.48% in the control group. Of patients in the case group, 9.9% used H2RAs, compared with 6.9% in the control group. Of patients in the case group, 8.3% used a combination of PPIs and H2RAs, compared with 2.7% in the control group. The most common etiological pathogens were Enterococcus (44.8%), Clostridioides difficile (34.5%), and Salmonella spp. (10.2%). The adjusted odds ratio (OR) for PPI use with enteric infection was 5.526 (95% confidence interval [CI], 5.274–5.791). For H2RAs, the adjusted odds ratio was 1.339 (95% confidence interval [CI], 1.261–1.424). Compared to the control group, persons with enteric infection had more frequent acid-suppressive agent usage. Conclusions: This study demonstrates that gastric-acid-suppressive drug use is associated with an increased risk of enteric infection after adjusting for potential biases and confounders. MDPI 2021-10-22 /pmc/articles/PMC8621954/ /pubmed/34834415 http://dx.doi.org/10.3390/jpm11111063 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kuo, Chia-Jung
Lin, Cheng-Yu
Chen, Chun-Wei
Hsu, Chiu-Yi
Hsieh, Sen-Yung
Chiu, Cheng-Tang
Lin, Wey-Ran
Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study
title Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study
title_full Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study
title_fullStr Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study
title_full_unstemmed Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study
title_short Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study
title_sort risk of enteric infection in patients with gastric acid supressive drugs: a population-based case-control study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621954/
https://www.ncbi.nlm.nih.gov/pubmed/34834415
http://dx.doi.org/10.3390/jpm11111063
work_keys_str_mv AT kuochiajung riskofentericinfectioninpatientswithgastricacidsupressivedrugsapopulationbasedcasecontrolstudy
AT linchengyu riskofentericinfectioninpatientswithgastricacidsupressivedrugsapopulationbasedcasecontrolstudy
AT chenchunwei riskofentericinfectioninpatientswithgastricacidsupressivedrugsapopulationbasedcasecontrolstudy
AT hsuchiuyi riskofentericinfectioninpatientswithgastricacidsupressivedrugsapopulationbasedcasecontrolstudy
AT hsiehsenyung riskofentericinfectioninpatientswithgastricacidsupressivedrugsapopulationbasedcasecontrolstudy
AT chiuchengtang riskofentericinfectioninpatientswithgastricacidsupressivedrugsapopulationbasedcasecontrolstudy
AT linweyran riskofentericinfectioninpatientswithgastricacidsupressivedrugsapopulationbasedcasecontrolstudy